(R)-3-Amino-1-Butanol CAS 61477-40-5 Purity >99,0% (GC) Dolutegravir Intermediate Factory
Shanghai Ruifu Chemical Co., Ltd. is the leading manufacturer and supplier of (R)-3-Amino-1-Butanol (CAS: 61477-40-5) with high quality, commercial production. It's an intermediate of Dolutegravir (CAS: 1051375-16-6). We can provide Certificate of Analysis (COA), worldwide delivery, small and bulk quantities available, strong after-sale service. Please contact: alvin@ruifuchem.com
Ngaran Kimia | (Urang Sunda) -3-Amino-1-Butanol |
sinonim | (R)-3-Aminobutan-1-ol;(3R)-3-Amino-1-Butanol |
Nomer CAS | 61477-40-5 |
Nomer CAT | RF-CC317 |
Status saham | Dina Stok, Skala Produksi Nepi ka Ton |
Formula Molekul | C4H11NO |
Beurat Molekul | 89.14 |
Gravitasi spésifik (20/20) | 0.95 |
Indéks réfraktif | 1.45 |
Rotasi Spésifik [α]20/D | -12.0° ~ -10.0° (C=1, EtOH) |
merek | Kimia Ruifu |
Penampilan | Teu warnaan ka Cairan Konéng Lampu | Cairan Konéng Lampu |
Idéntifikasi ku IR | Conforms kana Spéktrum Standar | Sasuai |
Idéntifikasi ku GC | Sasuai jeung Waktos Panyimpenan Standar | Sasuai |
Purity ku GC (A%) | >99.0% | 99,8% |
Zat Patali | Sakur Kotoran Tunggal: <0,5% | 0,09% |
Total Kotoran: <1,0% | 0,28% | |
S-Isomer (ku HPLC A%) | <0,10% | 0,02% |
Kandungan Cai ku KF | <0,50% | 0,10% |
Assay ku GC (w/w%) | >99.0% | 99,3% |
Bungkusan: Botol Fluorinated, 25kg / Drum, atawa nurutkeun sarat customer urang
Kaayaan Panyimpenan:Simpen dina wadah anu disegel dina tempat anu tiis sareng garing;Ngajaga tina cahaya sareng Uap
(R)-3-Amino-1-Butanol (CAS: 61477-40-5) tiasa dianggo salaku perantara dina persiapan sanyawa anu gaduh kagiatan ngahambat integrase HIV.(R)-3-Amino-1-Butanol mangrupikeun perantara Dolutegravir (CAS: 1051375-16-6).Dolutegravir (Tivicay) mangrupikeun ubar anti-ADIS énggal anu dikembangkeun babarengan ku raksasa farmasi Inggris GlaxoSmithKline (GSK) sareng Perusahaan Farmasi Shionogi Jepang (Shionogi).Dina Agustus 2013, FDA AS nyatujuan dolutegravir (ogé disebut S/GSK1349572) pikeun pengobatan inféksi HIV-1 di déwasa sareng murangkalih umur 12 taun sareng langkung ageung digabungkeun sareng obat antiretroviral sanés.